INVOLVEMENT OF PERFORIN/GRANZYME B-DEPENDENT SIGNALING PATHWAY IN CYTOTOXIC ACTIVITY OF DENDRITIC CELLS TOWARDS HUMAN GLIOBLASTOMA CELLS
https://doi.org/10.15789/1563-0625-2017-4-421-430
Abstract
Granule-mediated cytotoxicity of effector cells is a universal mechanism of tumor growth inhibition and induction of tumor cell death. The aim of present study was to evaluate expression of lytic molecules in DCs generated in presence of IFNα (IFN-DCs), and to analyze the role of granule-mediated mechanism for IFN-DC cytotoxic activity against tumor cell lines. IFN-DCs were generated by culturing of plastic-adherent peripheral blood mononuclear cells in presence of GM-CSF and IFNα for 4 d followed by LPS addition for 24 h. The tumor cell lines were obtained from malignant tissues from patients with glioblastoma multiforme. Maturation of IFN-DCs in presence of LPS was accompanied by accumulation of intracellular perforin and granzyme B molecules. Perforin expression showed a direct correlation with intracellular lysosome-associated membrane protein-1 (LAMP-1/CD107a) expression in LPS-stimulated IFN-DCs. However, CD107a expression did not increase under LPS stimulation. At the same time, LPS caused upregulated degranulation in IFN-DCs, as shown by an increase of surface CD107a expression on IFN-DCs. LPS activation of DCs generated from the same donors in the presence of GM-CSF and IL-4 (IL-4-DCs) did not influence perforin and granzyme B expression in IL-4-DCs which was significantly lower than in IFN-DCs. Intracellular pool of CD107a molecules was increased in response to LPS stimulation of IL-4-DCs, but surface CD107a expression did not change on IL-4-DCs. Studies of cytotoxic activity of LPS-stimulated IFN-DCs revealed that concanamicyn A (CMA), an inhibitor of vacuolar H+-ATPase and of perforin/granzyme B-mediated signaling pathway, caused reduced cytotoxicity of donor DCs towards glioblastoma cell lines. Involvement of perforin/granzyme B-signaling pathway into the DCs cytotoxicity was confirmed with glioblastoma cell lines, since blockage of this mechanism with vacuolar H+ ATPase blocker (CMA) caused inhibition of the IFN-DC cytotoxicity. Differently reduced DC cytotoxic activity by CMA may suggest that the glioblastoma cell lysis can be mediated via perforin/granzyme B-independent mechanisms.
About the Authors
T. V. TyrinovaRussian Federation
Tyrinova Tamara V. - PhD (Biology), Research Associate, Laboratory of Cellular Immunotherapy.
630099, Russian Federation, Novosibirsk, Yadrintsevskaya str., 14. Phone: 7 (383) 228-21-01. Fax: 7 (383) 222-70-28
O. Yu. Leplina
Russian Federation
PhD, MD (Medicine), Leading Research Associate, Laboratory of Cellular Immunotherapy.
NovosibirskS. V. Mishinov
Russian Federation
PhD (Medicine), Neurosurgeon, Neurosurgery Department.
NovosibirskM. A. Tikhonova
Russian Federation
PhD (Biology), Senior Research Associate, Laboratory of Cellular Immunotherapy.
NovosibirskA. V. Kalinovskiy
Russian Federation
PhD (Medicine), Head, Surgical Unit.
NovosibirskS. V. Chernov
Russian Federation
PhD (Medicine), Head, Neurooncology Department.
NovosibirskV. V. Stupak
Russian Federation
PhD, MD (Medicine), Professor, Head, Neurosurgery Department.
NovosibirskA. A. Ostanin
Russian Federation
PhD, MD (Medicine), Professor, Main Research Associate, Laboratory of Cellular Immunotherapy.
NovosibirskE. R. Chernykh
Russian Federation
PhD, MD (Medicine), Professor, Corresponding Member, Russian Academy of Sciences, Head, Laboratory of Cellular Immunotherapy.
NovosibirskReferences
1. Aktas E., Kucuksezer U.C., Bilgic S., Erten G., Deniz G., Relationship between CD107a expression and cytotoxic activity. Cell Immunol., 2009, Vol. 254, pp. 149-154.
2. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods, 2004, Vol. 294, no. 1-2, pp. 15-22.
3. Anguille S., Lion E., Tel J., de Vries I.J.M., Couderé K., Fromm P.D., Van Tendeloo V.F., Smits E.L., Berneman Z.N. Interleukin-15-induced CD56+ myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential. PLoS One, 2012, Vol. 7, e51851. doi:10.1371/journal.pone.0051851.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature, 1998, Vol. 392, pp. 245-252.
5. Barcia C. Jr., Gómez A., Gallego-Sanchez J.M., Perez-Vallés A., Castro M.G., Lowenstein P.R., Barcia C., Herrero M.-T. Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells. Am. J. Pathol., 2009, Vol. 175, pp. 786-798.
6. Bellail A.C., Tse M.C., Song J.H., Phuphanich S., Olson J.J., Sun S.Y., Hao C. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J. Cell Mol. Med., 2010, Vol. 14, no. 6A, pp. 1303-1317.
7. Bratke K., Nielsen J., Manig F., Klein C., Kuepper M., Geyer S., Julius P., Lommatzsch M., Virchow J.C. Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation. Clin. Exp. Allergy, 2010, Vol. 40, pp. 1015-1024.
8. Capper D., Gaiser T., Hartmann C., Habel A., Mueller W., Herold-Mende C., von Deimling A., Siegelin M.D. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathol., 2009, Vol. 117, no. 4, pp. 445-456.
9. Choi B.D., Gedeon P.C., HerndonII J.E., Archer G.E., Reap E.A., Sanchez-Perez L., Mitchell D.A., Bigner D.D., Sampson J.H. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunol. Res., 2013, Vol. 1, no. 3, pp. 163-167.
10. Clément M.V., Haddad P., Soulié A., Legros-Maida S., Guillet J., Cesar E., Sasportes M. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Res Immunol., 1990, Vol. 141, no. 6, pp. 477-489.
11. Cullen S.P., Brunet M., Martin S.J. Granzymes in cancer and immunity. Cell Death Differ., 2008, Vol. 17, no. 4, pp. 616-623.
12. Fanger N.A., Maliszewski C.R., Schooley K., Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med., 1999, Vol. 190, pp. 1155-1164.
13. Jahrsdörfer B., Vollmer A., Blackwell S.E., Maier J., Sontheimer K., Beyer T., Mandel B., Lunov O., Tron K., Nienhaus G.U., Simmet T., Debatin K.M., Weiner G.J., Fabricius D. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood, 2010, Vol. 115, no. 6, pp. 1156-1165.
14. Janjic B.M., Lu G., Pimenov A., Whiteside T.L., Storkus W.J., Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. I. involvement of an apoptosis-inducing pathway. J. Immunol., 2002, Vol. 168, pp. 1823-1830.
15. Karrich J.J., Jachimowski L.C.M., Nagasawa M., Kamp A., Balzarolo M., Wolkers M.C., Uittenbogaart C.H., Marieke van Ham S., Blom B. IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation. Blood, 2013, Vol. 121, no. 16, pp. 3103-3111.
16. Kataoka T., Takaku K., Magae J., Shinohara N., Takayama H., Kondo S., Nagai K. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity. J. Immunol., 1994, Vol. 153, no. 9, pp. 3938-3947.
17. Korthals M., Safaian N., Kronenwett R., Maihöfer D., Schott M., Papewalis C., Diaz Blanco E., Winter M., Czibere A., Haas R., Kobbe G., Fenk R. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J. Transl. Med., 2007, Vol. 5, p. 46.
18. Krzewski K., Gil-Krzewska A., Nguyen V., Peruzzi G., Coligan J.E. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood, 2013, Vol. 121, no. 23, pp. 4672-4683.
19. Liu Sh., Yu Y., Zhang M., Wang W., Cao X. The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells. J. Immunol., 2001, Vol. 166, no. 9, pp. 5407-5415.
20. Mori S., Jewett A., Murakami-Mori K., Cavalcanti M., Bonavida B. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol. Immunother., 1997, Vol. 44, pp. 282-290.
21. Ogbomo H., Zemp F.J., Lun X., Zhang J., Stack D., Rahman M.M., Mcfadden G., Mody C.H., Forsyth P.A. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo. PLoS One, 2013, Vol. 8, e66825. doi:10.1371/journal.pone.0066825.
22. Papewalis C., Jacobs B., Wuttke M., Ullrich E., Baehring T., Fenk R., Willenberg H.S., Schinner S., Cohnen M., Seissler J., Zacharowski K., Scherbaum W.A., Schott M. IFN-skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J. Immunol., 2008, Vol. 180, pp. 1462-1470.
23. Renner D., Jin F., Parney I., Pirko I., Pavelko K., Johnson A. A duality of roles for perforin in CD8+ T cellglioma interactions: contributions to cytotoxicity and altered vascular permeability. Neuro Oncol., 2014, Vol. 16 (suppl. 5), v109. doi:10.1093/neuonc/nou257.10.
24. Stary G., Bangert C., Tauber M., Strohal R., Kopp T., Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med., 2007, Vol. 204, pp. 1441-1451.
25. Tyrinova T.V., Leplina O.Y., Mishinov S.V., Tikhonova M.A., Shevela E.Y., Stupak V.V., Pendyurin I.V., Shilov A.G., Alyamkina E.A., Rubtsova N.V., Bogachev S.S., Ostanin A.A., Chernykh E.R. Cytotoxic activity of ex-vivo generated IFNα-induced monocyte-derived dendritic cells in brain glioma patients. Cell Immunol., 2013, Vol. 284, pp. 146-153.
26. Vanderheyde N., Vandenabeele P., Goldman M., Willems F. Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells. Immunol. Lett., 2004, Vol. 91, no. 2-3, pp. 99-101.
27. Zhang B., Zhang J., Tian Z. Comparison in the effects of IL-2, IL-12, IL-15 and IFNα on gene regulation of granzymes of human NK cell line NK-92. Int. Immunopharmacol., 2008, Vol. 8, pp. 989-996.
Review
For citations:
Tyrinova T.V., Leplina O.Yu., Mishinov S.V., Tikhonova M.A., Kalinovskiy A.V., Chernov S.V., Stupak V.V., Ostanin A.A., Chernykh E.R. INVOLVEMENT OF PERFORIN/GRANZYME B-DEPENDENT SIGNALING PATHWAY IN CYTOTOXIC ACTIVITY OF DENDRITIC CELLS TOWARDS HUMAN GLIOBLASTOMA CELLS. Medical Immunology (Russia). 2017;19(4):421-430. (In Russ.) https://doi.org/10.15789/1563-0625-2017-4-421-430